💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Five Prime Therapeutics, Inc. (FPRX)
« Back to company indexFPRX Chatter Timeline
Stock Ticker for FPRX
Most Active Tweeters for FPRX
| User | Tweets |
|---|---|
| @ChartMill | 1 |
| @RamsCharts | 1 |
| @Gambiste1 | 1 |
| @AlertTrade | 1 |
| @42Stocks | 1 |
Recent Tweets for FPRX
 |
@intratio $FPRX https://t.co/Bf3tPhlnVr Five Prime Therapeutics, Inc. The AI foresees that this stock s value will be stable… https://t.co/blB41J7fbJ October 22nd 2020, 7:10am |
 |
@AlertTrade REVERSALtoDOWN: $FPRX Five Prime Therapeutics, Inc https://t.co/krIPHxjuc5 ? ? TradeIdeas via ? https://t.co/ZgCyz4rX3x October 20th 2020, 12:10pm |
 |
@Gambiste1 RT @RamsCharts: $FPRX - Cup & Handle is getting ready to breakout. I would wait until we get the breakout confirmation. https://t.co/l7JeHv… October 17th 2020, 5:10pm |
 |
@RamsCharts $FPRX - Cup & Handle is getting ready to breakout. I would wait until we get the breakout confirmation. https://t.co/l7JeHvVxd4 October 17th 2020, 9:10am |
 |
@ChartMill $FPRX is currently showing a bull flag pattern! A bull flag pattern is a pull back after a strong rise up.… https://t.co/19UJenPuwY October 17th 2020, 3:10am |
 |
@IOInvestors Is Five Prime Therapeutics Inc $FPRX Stock Near the Top of the Biotechnology Industry? See Full Analysis:… https://t.co/rUlBsOne43 October 13th 2020, 11:10am |
 |
@Itradestk $FPRX - monitoring it...entry above $6.09 #??????_????????? https://t.co/Hq39xRJGJI October 12th 2020, 11:10pm |
 |
@42Stocks https://t.co/qXdYc72qro 2020-OCT-12 11:55am $FPRX #FivePrime_FPRX Five Prime · up 13.66% = $19.4 million gain.… https://t.co/pmiuLNMRLE October 12th 2020, 11:10am |
 |
@dispatchtribune Five Prime Therapeutics $FPRX Trading 8.8% Higher https://t.co/XwDhfDnxgC October 9th 2020, 10:10am |
 |
@EnterpriseLeade Five Prime Therapeutics $FPRX Trading 8.8% Higher https://t.co/dRE6dGVgA3 October 9th 2020, 10:10am |
 |
@hemonctrader $FPRX right at resistance if thru then next 6.17 https://t.co/4LvUCR54ZB October 9th 2020, 9:10am |
 |
@MarketChmln $FPRX gains in premarket trading. See vwap price action. https://t.co/2AbHpBv6Bp https://t.co/egw76KfHjE October 9th 2020, 9:10am |
|
@Gambiste1 RT @StockPlays: $FPRX Five Prime Therapeutics Form 4, Major Shareholder, BVF PARTNERS, buys 345241 shares @ $1,740,014.64 PLUS, Rating Inc… October 9th 2020, 9:10am |
 |
@StockPlays $FPRX Five Prime Therapeutics Form 4, Major Shareholder, BVF PARTNERS, buys 345241 shares @ $1,740,014.64 PLUS, Ra… https://t.co/zkRtwssubB October 9th 2020, 8:10am |
 |
@insiderbuyings $FPRX new insider buying: 345241 shares. https://t.co/2i5lt7hksw October 9th 2020, 3:10am |
 |
@aistockfinder $FPRX https://t.co/esM2vaXoeM Five Prime Therapeutics Inc. Our model is forecasting the value of this company has a… https://t.co/igsDFIU2tu October 9th 2020, 12:10am |
 |
@InsiderAlerts4U $FPRX: New Insider Filing on FIVE PRIME THERAPEUTICS, INC.'s 10%+ Owner BVF PARTNERS L P/IL: https://t.co/7dVZaORK4q October 8th 2020, 9:10pm |
 |
@HealthcareBeat Form SC 13D/A (general statement of acquisition of beneficial ownership) filed with the SEC $FPRX https://t.co/kqy0fMPdQ5 October 8th 2020, 8:10pm |
 |
@PaulGathua RT @fintel_io: Insider Mark N Lampert reports buying 345,241 shares of $FPRX for a total cost of $1,738,288.44 https://t.co/6LejWMAI5U October 8th 2020, 7:10pm |
|
@PaulGathua RT @formwhisperscom: #FWBuys $FPRX BVF PARTNERS L P/IL, 10%-owner of FIVE PRIME THERAPEUTICS, INC. bought 345,241 shares on 2020-10-06. htt… October 8th 2020, 7:10pm |
|
@PaulGathua RT @whalewisdom: New SC 13D/A from BIOTECHNOLOGY VALUE FUND L P concerning $FPRX. See details at https://t.co/6mp3yjTWEx October 8th 2020, 7:10pm |
 |
@whalewisdom New SC 13D/A from BIOTECHNOLOGY VALUE FUND L P concerning $FPRX. See details at https://t.co/6mp3yjTWEx October 8th 2020, 6:10pm |
|
@MonitorAction $FPRX FIVE PRIME THERAPEUTICS, INC. https://t.co/tN0A0x7fWn October 8th 2020, 6:10pm |
 |
@biotechwrestler RT @drug_smolecules: $FPRX has two read outs likely in Q4 ??Bema phase 2 FIGHT study (possibly 1q21 but doubtful) ??FPT155 monotherapy… October 8th 2020, 5:10pm |
 |
@InsiderForms $FPRX Biotechnology VALUE FUND L P has filed Form SC 13D/A with SEC. Reporting 22.8% Ownership. https://t.co/t5CkFUZh7T October 8th 2020, 5:10pm |
 |
@fintel_io Insider Mark N Lampert reports buying 345,241 shares of $FPRX for a total cost of $1,738,288.44 https://t.co/6LejWMAI5U October 8th 2020, 5:10pm |
 |
@formwhisperscom #FWBuys $FPRX BVF PARTNERS L P/IL, 10%-owner of FIVE PRIME THERAPEUTICS, INC. bought 345,241 shares on 2020-10-06. https://t.co/nIJSfGixH7 October 8th 2020, 5:10pm |
|
@fintel_io Biotechnology Value Fund L P has filed an amended 13D/A, reporting 22.8% ownership in $FPRX - https://t.co/SBS4uxymIi October 8th 2020, 5:10pm |
 |
@AmericanBanking Five Prime Therapeutics $FPRX Shares Up 8.8% https://t.co/LSrz1zoQvT #stocks October 7th 2020, 7:10pm |
 |
@DenisDubuy @drug_smolecules I agree on $FPRX hated stock since CSF1R failure. 2 near term milestones with CD80-Fc fusion p1a d… https://t.co/lrTwa8Fhx5 October 7th 2020, 4:10pm |
 |
@SADIFAnalytics Is Five Prime Therapeutics Inc Worth a Higher Bid? $FPRX https://t.co/WkK2CNZxdW October 7th 2020, 3:10pm |
 |
@PMDiChristina This was one of my favorites. Still early $FPRX “not ? science” October 7th 2020, 2:10pm |
|
@hemonctrader $FPRX Strong momentum since highlighted. $6.02 resistance level. https://t.co/Z39BR8XLyE October 7th 2020, 10:10am |
 |
@drug_smolecules @nociFTW $FPRX FGFR2b/bem has monotherapy activity; translate to additive combo? The selection strategy is stringen… https://t.co/g5owPMNWgQ October 7th 2020, 7:10am |
 |
@WatchlistN Five Prime Therapeutics Inc $FPRX Receives $10.00 Average PT from Brokerages https://t.co/AWnTUrnO9W October 7th 2020, 5:10am |
 |
@nociFTW @drug_smolecules Do you have any additional thoughts on $fprx? Agree they are interesting at this price. Hated name… https://t.co/0Jnh9KGoqs October 7th 2020, 2:10am |
|
@drug_smolecules Cigar butt investing for 4Q20 1. $FPRX 2. $CNCE 1. Monotherapy activity + combo = something interesting 2. D-Seri… https://t.co/Xy8Ijc7jvL October 6th 2020, 9:10pm |
 |
@BiotechHeiko Sold $FPRX for 12% gain and bought $NBIX October 6th 2020, 10:10am |
 |
@TradeFlags TD SELL $FPRX at 4.86, Supp 3.83 Resis 4.92 R28 HiLo 56% T1Y 9 buy 2.0 fwdPE -2.3 DIV N/A #Five Prime #stocks… https://t.co/AdyDk7PGkl October 5th 2020, 10:10pm |
|
@InsiderAlerts4U $FPRX: New Insider Filing on FIVE PRIME THERAPEUTICS, INC.'s Insider DAVID WHITE: https://t.co/wQ5opy50V2 October 2nd 2020, 2:10pm |
|
@HealthcareBeat $32,505.20 of shares sold by White David (See Remarks), reported in a new form 4 filed with the SEC $FPRX https://t.co/YpcOGvN1wW October 2nd 2020, 1:10pm |
 |
@FlashAlert_me $FPRX [15s. delayed] filed SEC form 4: See Remarks White David: Delivered securities 6,916 of Common Stock at pric… https://t.co/3AlCqwjRhq October 2nd 2020, 1:10pm |
|
@StockPlays $FPRX Five Prime Therapeutics presentation. Good things are coming in the not too distant future… https://t.co/dwe1BT1434 October 1st 2020, 3:10pm |
|
@StockPlays @anyatrades $NIO and $FPRX October 1st 2020, 1:10pm |
|
@drug_smolecules $FPRX has two read outs likely in Q4 ??Bema phase 2 FIGHT study (possibly 1q21 but doubtful) ??FPT155 monotherapy… https://t.co/TJVlqfPciw September 30th 2020, 9:09pm |
|
@EnterpriseLeade $3.50 Million in Sales Expected for Five Prime Therapeutics Inc $FPRX This Quarter https://t.co/VLFXluot3T September 30th 2020, 4:09am |
|
@AlertTrade DYNAMOgapDOWN $FPRX - Five Prime Therapeutics, Inc https://t.co/7QvyZ6l5lY via ? https://t.co/VS8RO1bzXJ September 28th 2020, 11:09am |
 |
@ConsumerFeed Five Prime Therapeutics $FPRX Upgraded at Guggenheim https://t.co/g45Y8ylfli September 25th 2020, 3:09am |
|
@aistockfinder $FPRX https://t.co/esM2vaXoeM Five Prime Therapeutics Inc. The current setup has detected that this stock price wil… https://t.co/BJOW7ez5ns September 25th 2020, 3:09am |
|
@drug_smolecules Bvf bought 32 shares of $FPRX on Tuesday. Absolutely unhinged, mad lads. https://t.co/nt1dwzv0FM September 24th 2020, 9:09pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
